Mayne Pharma Group Limited carries a market capitalization of 160.30M, placing it among publicly traded companies globally.
| Market Cap | 160.30M |
| Enterprise Value | N/A |
Mayne Pharma Group Limited's stock has declined approximately -43.94886% over the past 52 weeks. The 50-day moving average sits at 1.70, while the 200-day moving average is 2.19.
| Beta (5Y) | N/A |
| 52-Week Price Change | -43.94886% |
| 50-Day Moving Average | 1.70 |
| 200-Day Moving Average | 2.19 |
| Average Volume (20 Days) | N/A |
Mayne Pharma Group Limited's most recent stock split took place on January 18, 2023 with a 20:1 split ratio.
| Last Split Date | 1/18/2023 |
| Split Ratio | 20:1 |